Scientific Collaborators

About Us

Gibson Oncology has been fortunate to work with senior scientists from the National Institute of Neurological Disorders and Stroke, the National Cancer Institute, and major universities. In addition, significant research components for the Gibson Oncology pipeline were performed under preclinical and clinical grants.

Mark S. Cushman, PhD., PharmD

Distinguished Professor of Medicinal Chemistry at Purdue University Chief Scientific Officer Board Member

Manmeet Ahluwalia, MD, MBA

Chief of Solid Tumor Medical Oncology, Chief Scientific Officer & Deputy Director Miami Cancer Institute

Desmond A. Brown, MD., PhD

Assistant Clinical Investigator & Head of Neurosurgical Oncology at National Institute of Neurological Disorders and Stroke (NINDS)

Pooran Chand, PhD

CEO and Co-Founder of Therachem Research Medialab

Yves Pommier, MD., PhD.

Senior Investigator Development Therapeutics Branch NCI/CCR

Matthew Waitkus, PhD

Assistant Professor in Neurosurgery Assistant Professor of Pathology Member of the Duke Cancer Institute

Graeme F. Woodworth, M.D., FAANS, FACS

Professor and Chair, Department of Neurosurgery Director, Brain Tumor Treatment and Research Center University of Maryland School of Medicine

Jing Wu, M.D., Ph.D.

Center for Cancer Research-NIH Lasker Clinical Research Scholar Neuro-Oncology Branch

Danzhou Yang, PhD

Distinguished Professor |Medicinal Chemistry and Molecular Pharmacology, Analytical Chemistry, Biochemistry at Purdue University

Michael Zinner, MD

Chief Executive Officer & Medical Director, Miami Cancer Institute Former Professor & Chair of the Dept of Surgery, Harvard Medical School

Sadhana Jackson, M.D.

NIH Investigator, Head of Developmental Therapeutics & Pharmacology, Surgical Neurology Branch, Pediatric Oncology Branch, NINDS/NCI